A Clinical Trial of Safety and Tolerance of TQH3821 Tablets in Adult Healthy Subjects

Clinical trial NCT05380934 · COMPLETED

Trial details

NCT number: NCT05380934
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2022-05-29
Primary completion: 2023-05-20
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.